POCT Glucose and Ketones
[POCT Glucose and Ketones]
EPTIS factsheet 142647 | Last revision 2024-05-22 | URL: https://www.eptis.bam.de/pts142647 https://www.eptis.bam.de/pts142647
| PT provider | ||||||||||
| PT provider | Weqas Weqas | |||||||||
| Based in | United Kingdom | |||||||||
| Language(s) | ||||||||||
| Remarks | The measurement of capillary blood glucose using Point of Care Testing (POCT) devices is widespread across the UK, Europe and North America; with the NHS in the UK spending £165 M in primary care and £16.7 M in secondary care in 2018/ 19 on POCT devices and strips. The programme is a standard programme, as a managed service or offered as part of a contract with your POCT device supplier. Our Managed Service is designed for sites that do not have the support of a local laboratory Point of Care Department for performance oversight. A suite of reports is available, for both the end user and the POCT Co-ordinator. Ready to use plasma samples are provided in sterile dropper bottles containing both glucose and ketones. The POCT Co-ordinator (or organisational lead) can choose whether to assess each operator or each meter. One level is provided per distribution for each meter, where they can choose to receive samples monthly, bimonthly or quarterly and either sent directly to the POCT site or to the POCT Co-ordinators to distribute. The analytical range of 2.0 to 30.0 mmol/L for glucose and 0.6 to 6 mmol/l for ketone is covered over the 12 month period. Samples at key clinical targets of 2.0, 7.0, and 11.0 mmol/l for glucose and 0.6 and 3 mmol/l for ketones are covered as a minimum. Key Features: - Ready to use liquid samples in sterile dropper vials containing both glucose and ketones. - Suitable for all glucose Meters. - Sites or individual users can be assessed. - POCT Co-ordinator summary reports. - POCT Co-ordinator poor performance reports. - POCT Co-ordinators “non -return” reports. - Simple traffic light reports for end users. - Panel of samples covering the pathological range. - Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/poct-eqa/poct-glucose/ or contact@weqas.com | |||||||||
| Keywords | ||||||||||
| Product groups |
Health care / medical devices
|
|||||||||
| Testing fields |
Medical analysis
|
|||||||||
| Technical details | ||||||||||
|
||||||||||
| Aims of the PT scheme | ||||||||||
| Target group of participants | The programme is available directly from Weqas as a standard programme, as a managed service or offered as part of a contract with your POCT device supplier. | |||||||||
| Linked to specific legislation / standards | Accreditation by UKAS based on ISO/IEC 17043. | |||||||||
| Additional, subsidiary aims | validation of testing methods | |||||||||
| Number of participants | ||||||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by UKAS on the basis of ISO/IEC 17043 |
|||||||||
| Operation is commissioned / requested by | ||||||||||
| Fees and frequency | ||||||||||
| Participation fee | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||
| Regularly operated | Yes (Frequency: Monthly, Bimonthly or Quarterly. Samples: 1 x 0.5mL.) | |||||||||
| Year of first operation | POCT Glucose 1995, POCT Ketones 2008 | |||||||||
| Contact details of the PT provider | ||||||||||
| Provider | Contact person | |||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Phone: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Phone: 44 (0) 29218 32884 Fax: Email: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.